{"id":"W4221079817","doi":"10.1210/clinem/dgac154","title":"Empagliflozin and Decreased Risk of Nephrolithiasis: A Potential New Role for SGLT2 Inhibition?","year":2022,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"National Center for Advancing Translational Sciences; Esperion Therapeutics; Sanofi; Pfizer; National Institute of Diabetes and Digestive and Kidney Diseases; Boehringer Ingelheim; AstraZeneca; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Placebo; Internal medicine; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Incidence (geometry); Urinary system; Meta-analysis; Clinical trial; Hazard ratio; Urology; Confidence interval; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02045538,0.0009147222,0.003017111,0.0006526853,0.0001800922,0.0017729,0.00100866,0.001843101,0.004728542],"category_scores_gemma":[0.02461349,0.0003827749,0.003444311,0.0008285594,0.001617358,0.002269732,0.0007067793,0.002422334,0.0002980022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007648111,"about_ca_system_score_gemma":0.001026026,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009652794,"about_ca_topic_score_gemma":0.001158921,"domain_scores_codex":[0.9963979,0.002183445,0.0003315218,0.0005100566,0.0004417941,0.0001354076],"domain_scores_gemma":[0.9723929,0.02076601,0.003792692,0.001390542,0.001099974,0.0005578999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1035766,0.001058569,0.1113035,0.01438317,0.0590726,0.001677982,0.0004535175,0.005991877,0.008551694,0.01534726,0.01894717,0.659636],"study_design_scores_gemma":[0.03533384,0.03540307,0.5577947,0.01277134,0.07703412,0.005641653,0.0008664289,0.01604741,0.007229271,0.08799252,0.16327,0.0006156629],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1596723,0.7378317,0.008719895,0.08375308,0.003233424,0.0001457004,0.000835661,0.0001663754,0.005641801],"genre_scores_gemma":[0.717667,0.2136621,0.005953261,0.03961097,0.02028912,0.0001977196,0.0005600149,0.00006896149,0.001990807],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02045538,"threshold_uncertainty_score":0.1081796,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02730299453607768,"score_gpt":0.3443304563574596,"score_spread":0.317027461821382,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}